A detailed history of Gerber, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Gerber, LLC holds 30,800 shares of INVA stock, worth $549,472. This represents 0.44% of its overall portfolio holdings.

Number of Shares
30,800
Previous 34,300 10.2%
Holding current value
$549,472
Previous $563 Million 5.73%
% of portfolio
0.44%
Previous 0.44%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$16.33 - $20.04 $57,154 - $70,140
-3,500 Reduced 10.2%
30,800 $595 Million
Q4 2023

Mar 05, 2024

BUY
$12.32 - $16.27 $422,576 - $558,061
34,300 New
34,300 $550 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.24B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Gerber, LLC Portfolio

Follow Gerber, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gerber, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gerber, LLC with notifications on news.